<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00764959</url>
  </required_header>
  <id_info>
    <org_study_id>PS - 800</org_study_id>
    <nct_id>NCT00764959</nct_id>
  </id_info>
  <brief_title>Retrospective Study of the Linear™ Hip</brief_title>
  <official_title>Post-Market Study of the Linear™ Hip System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Encore Medical, L.P.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Encore Medical, L.P.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip
      System in a group of 200 patients for whom data has already been collected.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Enrollment and data collection insufficient to continue study.
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The use and efficacy of the Encore Linear™ Hip System</measure>
    <time_frame>2 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Femoral Fracture</condition>
  <condition>Correction of a Functional Deformity</condition>
  <condition>Avascular Necrosis</condition>
  <arm_group>
    <arm_group_label>Linear Hip</arm_group_label>
    <description>Encore Linear Hip System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Encore Linear™ Hip System</intervention_name>
    <description>Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.</description>
    <arm_group_label>Linear Hip</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals who meet the indications for use of the Linear Hip device AND who meet the
        inclusion/exclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have hip joint disease related to one or more of the following

               -  osteoarthritis

               -  rheumatoid arthritis

               -  femoral fracture

               -  correction of a functional deformity

               -  avascular necrosis of the natural femoral head

          -  Skeletal maturity

          -  Patient is likely to be available for evaluation for the duration of the study

          -  Able and willing to sign the informed consent and follow study procedures

          -  Patient is not pregnant

          -  No infection present

          -  No known materials sensitivity

          -  Patient is over 18 years of age

        Exclusion Criteria:

          -  Skeletal immaturity

          -  Infection or sepsis

          -  Insufficient bone quality that may affect the stability of the implant

          -  Muscular, neurologic or vascular deficiencies which compromise the affected extremity

          -  Alcoholism or other addictions

          -  Prisoners

          -  High levels of physical activity

          -  Patient is pregnant

          -  Loss of ligamentous structures

          -  Materials sensitivity

          -  Patient is under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Hussamy, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hussamy Orthopedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hussamy Orthopedics</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.djosurgical.com</url>
    <description>Sponsor Company home page</description>
  </link>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2008</study_first_submitted>
  <study_first_submitted_qc>October 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2008</study_first_posted>
  <last_update_submitted>February 8, 2011</last_update_submitted>
  <last_update_submitted_qc>February 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jane M. Jacob Ph.D.</name_title>
    <organization>DJO Surgical</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

